510(k) K162227

STA® - Liatest® D-Di by Diagnostica Stago — Product Code DAP

K162227 is an FDA 510(k) premarket notification submitted by Diagnostica Stago for the device "STA® - Liatest® D-Di". The FDA issued a decision of Substantially Equivalent on Dec 10, 2016. The device falls under product code DAP (Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control), a Class II device regulated under 21 CFR 864.7320. Diagnostica Stago has 21 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Dec 10, 2016
Date Received
Aug 8, 2016
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Fibrinogen And Fibrin Split Products, Antigen, Antiserum, Control
Device Class
Class II
Regulation Number
864.7320
Review Panel
HE
Submission Type
510(k)

Need the full FDA record for Diagnostica Stago? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K162227. Report a data issue: hello@regdatalab.com.